deltatrials
Completed PHASE2 NCT00263705

Adjuvant Capecitabine in Elderly Patients With Breast Cancer: a Phase II Study

Sponsor: Jules Bordet Institute

Conditions Breast Cancer Elderly Patients
Interventions Adjuvant capecitabine capecitabine in aduvant setting
Updated 5 times since 2017 Last updated: Feb 23, 2011 Started: Jan 31, 2003 Primary completion: Aug 31, 2009 Completion: Aug 31, 2009

Listed as NCT00263705, this PHASE2 trial focuses on Breast Cancer and Elderly Patients and remains completed. Sponsored by Jules Bordet Institute, it has been updated 5 times since 2003, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Change History

5 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE2

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE2

  4. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE2

  5. Jan 2017 — Jun 2018 [monthly]

    Completed PHASE2

    First recorded

Jan 2003

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Jules Bordet Institute
Data source: Jules Bordet Institute

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Brussels, Belgium